background image

Moderna Clinical Trials

Find clinical trials for Moderna. Search for Moderna clinical trials in different cities and states across the United States.

Filter
Active & Responsive

The Impact of COVID-19 on Maternal and Neonatal Outcomes

for
COVID-19, Pregnancy; Infection
Location: 1 recruiting location
Sponsor: Johns Hopkins University

Sex: Female

Age: 14 - 55

Code: NCT05197621

Recruiting
Active & Responsive

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

for
COVID-19, Long Haul
Location: 1 recruiting location
Sponsor: Well- Konnect Healthcare Services and Research Firm

Sex: All

Age: 18 - 65

Code: NCT06441955

Recruiting
Active & Responsive

Systems Biological Analysis of Immune Responses to RSV Vaccine

for
Respiratory Syncytial Virus (RSV)
Location: 1 recruiting location
Sponsor: Emory University

Sex: All

Age: 60+

Code: NCT07185399

Recruiting
Active & Responsive

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

for
Propionic Acidemia
Location: 7 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05130437

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

for
SARS-CoV-2
Location: 26 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 0 - 5

Code: NCT05436834

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors

for
Advanced Solid Tumors
Location: 3 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT06880549

Phase1, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

for
Cytomegalovirus Infection
Location: 1 recruiting location
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT05683457

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

for
SARS-CoV-2
Location: 5 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 12+

Code: NCT06585241

Recruiting
Active & Responsive

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

for
COVID-19
Location: 5 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 12+

Code: NCT07089706

Recruiting
Active & Responsive

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: 1 recruiting location
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase1, Phase2, Recruiting